{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:59:10Z","timestamp":1791273550140,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1111\/1469-0691.12426","type":"journal-article","created":{"date-parts":[[2013,10,14]],"date-time":"2013-10-14T11:31:32Z","timestamp":1381750292000},"page":"1115-1121","source":"Crossref","is-referenced-by-count":36,"title":["Management and diagnostic guidelines for fungal diseases in infectious diseases and clinical microbiology: critical appraisal"],"prefix":"10.1016","volume":"19","author":[{"given":"S.","family":"Leroux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Ullmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/1469-0691.12426_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12037","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases","volume":"18","author":"Ullmann","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12426_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1469-0691.12038","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures","volume":"18","author":"Cuenca\u2010Estrella","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12426_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases: non\u2010neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12426_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1469-0691.12040","article-title":"ESCMID guideline for the diagnosis and the management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp","volume":"18","author":"Hope","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12426_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1469-0691.12041","article-title":"ESCMID guideline for the diagnosis and the management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)","volume":"18","author":"Ullmann","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12426_bib6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/1469-0691.12042","article-title":"ESCMID guideline for the diagnosis and the management of Candida diseases 2012: patients with HIV infection or AIDS","volume":"18","author":"Lortholary","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"Supplement 2","key":"10.1111\/1469-0691.12426_bib7","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12426_bib8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12426_bib9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1111\/1469-0691.12426_bib10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bmt.2010.175","article-title":"European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3\u20132009 update","volume":"46","author":"Maertens","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/1469-0691.12426_bib11","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/bmt.2011.178","article-title":"ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients","volume":"47","author":"Marchetti","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/1469-0691.12426_bib12","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3324\/haematol.2012.065110","article-title":"Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3)","volume":"98","author":"Skiada","year":"2013","journal-title":"Haematologica"},{"key":"10.1111\/1469-0691.12426_bib13","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/bmt.2011.246","article-title":"ECIL\u20103 classical diagnostic procedures for the diagnosis of invasive fungal diseases in patients with leukaemia","volume":"47","author":"Arendrup","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1111\/1469-0691.12426_bib14","author":"GRADE WORKING GROUP"},{"key":"10.1111\/1469-0691.12426_bib15","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","article-title":"Anidulafungin versus fluconazole for invasive candidiasis","volume":"356","author":"Reboli","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12426_bib16","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1469-0691.2010.03456.x","article-title":"Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007","volume":"17","author":"Skiada","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/1469-0691.12426_bib17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/1040841X.2012.711741","article-title":"Mucormycosis treated with posaconazole: review of 96 case reports","volume":"39","author":"Vehreschild","year":"2013","journal-title":"Crit Rev Microbiol"},{"key":"10.1111\/1469-0691.12426_bib18","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1093\/jac\/dks256","article-title":"Adherence to recommendations for the use of antifungal agents in a tertiary care hospital","volume":"67","author":"Nivoix","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/1469-0691.12426_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.diagmicrobio.2004.12.010","article-title":"Initial management of candidemia at an academic medical center: evaluation of the IDSA guidelines","volume":"52","author":"Patel","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1111\/1469-0691.12426_bib20","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1093\/jac\/dkq240","article-title":"Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM\u20102008B study)","volume":"65","author":"Pagano","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"suppl 2","key":"10.1111\/1469-0691.12426_bib21","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1016\/S0924-8579(08)70018-9","article-title":"Critical overview of clinical guidelines relating to invasive fungal infections","volume":"32","author":"Sa","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/1469-0691.12426_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/QCO.0b013e32834e0680","article-title":"The case for antifungal stewardship","volume":"25","author":"Ananda\u2010Rajah","year":"2012","journal-title":"Curr Opin Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14630767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14630767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T02:20:02Z","timestamp":1646792402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14630767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1198743X14630767"],"URL":"https:\/\/doi.org\/10.1111\/1469-0691.12426","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}